Literature DB >> 10514174

Reasons for not seeing drug representatives. They should be seen because they are a good resource.

R Tiner.   

Abstract

Mesh:

Year:  1999        PMID: 10514174      PMCID: PMC1116765     

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  1 in total

1.  Reasons for not seeing drug representatives.

Authors:  D Griffith
Journal:  BMJ       Date:  1999-07-10
  1 in total
  2 in total

1.  Analysis of US Food and Drug Administration Warning Letters: False Promotional Claims Relating to Prescription and Over-the-Counter Medications.

Authors:  Maribel Salas; Michelle Martin; Maria Pisu; Erin McCall; Alvaro Zuluaga; Stephen P Glasser
Journal:  Pharmaceut Med       Date:  2008-03-01

2.  Characteristics and impact of drug detailing for gabapentin.

Authors:  Michael A Steinman; G Michael Harper; Mary-Margaret Chren; C Seth Landefeld; Lisa A Bero
Journal:  PLoS Med       Date:  2007-04       Impact factor: 11.069

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.